InsidersTradesSigma
Discover the full record of transactions filed by Lock Kenneth A., Directeur Commercial. Officer active across 1 company, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 2 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €15k. History available since 1 March 2022. The latest transaction was disclosed on 3 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Lock Kenneth A. serves as the Chief Commercial Officer of Arcutis Biotherapeutics, Inc. He is responsible for the company's commercial strategy, including sales development and marketing. His expertise in the biopharmaceutical sector is crucial for the success of the company's commercial initiatives.